Rallybio Corporation (RLYB) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Rallybio Corporation (RLYB), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Rallybio Corporation, analysts forecast revenue rising from $673,750 in 2024 to $89.00M in 2029; the average estimate for 2029 earnings per share is $3.92; 3 analysts contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Rallybio Corporation (RLYB) forecast — frequently asked questions
What are analysts forecasting for Rallybio Corporation's earnings?
The average analyst estimate for Rallybio Corporation (RLYB) earnings per share in 2029 is 3.92, with individual estimates between 3.92 and 3.92.
How much revenue is Rallybio Corporation expected to make?
Analysts forecast Rallybio Corporation (RLYB) revenue of $89.00M in 2029, based on 1 published estimates.
How many analysts cover RLYB?
3 analysts contribute estimates for Rallybio Corporation (RLYB). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.